Dave, Your cost for the cannabis prescription, is the only thing wrong with the program. That product should be much cheaper than that, but when pharacutical companies get involved the price is always, almost unmanageable. I have a similar situation with my wife's cancer drug "Revlimid." it is $33,500 (retail) for 21 pills, which is a month's supply. I have retirement insurance, and additional supplemental insurance, but with that it is still $11,000 per month. I was lucky enough to get a grant from a charitable trust to pay for most of the balance of the cost for this year, because I am a pensioner, making less than 100k per year in retirement. This is my wife's 2nd year on this med. What happens after another year...who knows. I am sure the price will come down in 2020, after the patent expires on the product.